Epigral [EPIGRAL] vs Tata Chemicals [TATACHEM] Detailed Stock Comparison

Epigral Ltd.

NSE
Loading...

Tata Chemicals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Epigral Ltd. wins in 12 metrics, Tata Chemicals Ltd. wins in 8 metrics, with 0 ties. Epigral Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Epigral Ltd. Tata Chemicals Ltd. Better
P/E Ratio (TTM) 15.30 108.83 Epigral Ltd.
Price-to-Book Ratio 2.46 0.79 Tata Chemicals Ltd.
Debt-to-Equity Ratio 25.57 32.13 Epigral Ltd.
PEG Ratio -0.24 -0.74 Epigral Ltd.
EV/EBITDA 10.43 14.05 Epigral Ltd.
Profit Margin (TTM) 13.97% 1.23% Epigral Ltd.
Operating Margin (TTM) 10.05% 1.47% Epigral Ltd.
EBITDA Margin (TTM) 10.05% 1.47% Epigral Ltd.
Return on Equity 18.78% 1.04% Epigral Ltd.
Return on Assets (TTM) 11.35% 0.62% Epigral Ltd.
Free Cash Flow (TTM) $2.46B $-2.44B Epigral Ltd.
Dividend Yield 0.64% 1.19% Tata Chemicals Ltd.
1-Year Return -34.78% -14.56% Tata Chemicals Ltd.
Price-to-Sales Ratio (TTM) 2.14 1.21 Tata Chemicals Ltd.
Enterprise Value $56.94B $253.78B Tata Chemicals Ltd.
EV/Revenue Ratio 2.35 1.73 Tata Chemicals Ltd.
Gross Profit Margin (TTM) 40.02% 77.13% Tata Chemicals Ltd.
Revenue per Share (TTM) $561 $575 Tata Chemicals Ltd.
Earnings per Share (Diluted) $78.29 $6.37 Epigral Ltd.
Beta (Stock Volatility) -0.24 0.30 Epigral Ltd.

Epigral Ltd. vs Tata Chemicals Ltd. Stock Performance Analysis

Loading Price Chart...

EPIGRAL
TATACHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Epigral Ltd.-0.82%-8.50%-14.24%30.89%-23.83%-9.75%
Tata Chemicals Ltd.-2.49%-5.84%-8.40%3.89%-6.55%-1.74%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Epigral Ltd.-34.78%15.64%15.64%15.64%15.64%15.64%
Tata Chemicals Ltd.-14.56%-21.84%1.59%300.80%360.37%674.42%

Performance & Financial Health Analysis: Epigral Ltd. vs Tata Chemicals Ltd.

MetricEPIGRALTATACHEM
Market Information
Market Cap i₹51.57B₹176.61B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i94,6612,143,498
90 Day Avg. Volume i87,5791,505,258
Last Close₹1,130.20₹719.75
52 Week Range₹807.00 - ₹2,114.00₹580.30 - ₹1,026.65
% from 52W High-46.54%-29.89%
All-Time High₹2,406.75 (Sep 30, 2024)₹1,349.00 (Mar 04, 2024)
% from All-Time High-53.04%-46.65%
Growth Metrics
Quarterly Revenue Growth-0.08%-0.01%
Quarterly Earnings Growth-0.62%-0.11%
Financial Health
Profit Margin (TTM) i0.14%0.01%
Operating Margin (TTM) i0.10%0.01%
Return on Equity (TTM) i0.19%0.01%
Debt to Equity (MRQ) i25.5732.13
Cash & Liquidity
Book Value per Share (MRQ)₹486.92₹876.78
Cash per Share (MRQ)₹8.58₹44.55
Operating Cash Flow (TTM) i₹4.17B₹11.31B
Levered Free Cash Flow (TTM) i₹3.58B₹2.35B
Dividends
Last 12-Month Dividend Yield i0.64%1.19%
Last 12-Month Dividend i₹11.00₹11.00

Valuation & Enterprise Metrics Analysis: Epigral Ltd. vs Tata Chemicals Ltd.

MetricEPIGRAL (Apr 24, 2026)TATACHEM (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i15.30108.83
Forward P/E i14.9026.00
PEG Ratio i-0.24-0.74
Price to Sales (TTM) i2.141.21
Price to Book (MRQ) i2.460.79
Market Capitalization
Market Capitalization i₹51.57B₹176.61B
Enterprise Value i₹56.94B₹253.78B
Enterprise Value Metrics
Enterprise to Revenue i2.351.73
Enterprise to EBITDA i10.4314.05
Risk & Other Metrics
Beta i-0.240.30
Book Value per Share (MRQ) i₹486.92₹876.78

Financial Statements Comparison: Epigral Ltd. vs Tata Chemicals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEPIGRAL (2025)TATACHEM (2025)
Revenue/Sales i25.14B147.75B
Cost of Goods Sold i14.09B36.75B
COGS % of Revenue i56.0%24.9%
Gross Profit i11.05B111.00B
Gross Margin i44.0%75.1%
Research & Development i5.50MN/A
Operating Income (EBIT) i5.78B8.32B
Operating Margin i23.0%5.6%
EBITDA i7.15B21.88B
EBITDA Margin i28.4%14.8%
Pre-Tax Income i5.41B5.21B
Pre-Tax Income % of Revenue i21.5%3.5%
Income Tax i1.83B1.67B
Income Tax % of Revenue i7.3%1.1%
Net Income (Profit) i3.58B3.87B
Profit Margin i14.2%2.6%

Balance Sheet & Liquidity Metrics

MetricEPIGRAL (2025)TATACHEM (2025)
Cash & Equivalents i186.40M5.48B
Total Current Assets i7.75B67.20B
Total Current Assets % of Revenue i30.8%45.5%
Total Current Liabilities i4.93B61.39B
Total Current Liabilities % of Revenue i19.6%41.5%
Long-Term Debt i4.52B48.16B
Long-Term Debt % of Revenue i18.0%32.6%
Total Shareholders Equity i19.05B225.01B
Retained Earnings i17.85B92.79B
Retained Earnings % of Revenue i71.0%62.8%
Property, Plant & Equipment i22.19B4.31B

Cash Flow Statement Comparison

MetricEPIGRAL (2025)TATACHEM (2025)
Operating Cash Flow i4.17B11.31B
Operating Cash Flow % of Revenue i16.6%7.7%
Capital Expenditures i-1.86B-19.52B
Free Cash Flow i2.46B-2.44B
FCF Margin i9.8%-1.7%
Debt Repayment i-2.49B-26.86B
Common Stock Repurchase i-950.00MN/A

Short Interest & Institutional Ownership Analysis

MetricEPIGRALTATACHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i43.14M254.76M
Float Shares i13.33M156.09M
% Held by Insiders i68.86%38.72%
% Held by Institutions i5.82%27.14%
% Held by Public i25.32%34.14%

Dividend Analysis & Yield Comparison: Epigral Ltd. vs Tata Chemicals Ltd.

MetricEPIGRALTATACHEM
Last 12-Month Dividend i₹11.00₹11.00
Last 12-Month Dividend Yield i0.64%1.19%
3-Year Avg Annual Dividend i₹3.67₹14.50
3-Year Avg Dividend Yield i0.22%1.45%
3-Year Total Dividends i₹11.00₹43.50
Ex-Dividend DateJun 20, 2025Jun 12, 2025